Supplemental Readings and References
451
and ABC 1-mediated efflux of cholesterol by RXR heterodimers.
S cien ce
2 8 9 , 1524(2000).
P. M. Ridker, M. Cushman, M. J. Stampfer, et al.: Inflammation, aspirin and
the risk of cardiovascular disease in apparently healthy men.
N ew E n g la n d
J o u rn a l o f M ed ic in e
336,973 (1997).
R. Ross: Atherosclerosis—An inflammatory disease.
N ew E n g la n d Jo u rn a l
o f M ed icin e
3 4 0 , 115 (1999).
H. B. Rubins, S. J. Robins, D. Collins, et al.: Gemfibrozil for the secondary
prevention of coronary heart disease in men with low levels of high-
density lipoprotein cholesterol.
N ew E n g la n d J o u rn a l o f M ed icin e
3 4 1 ,
410(1999).
C. von Schakey, R Angerer, W. Kotheny, et al.: The effect of dietary
co-3
fatty acids on coronary atherosclerosis: A randomized, double-blind,
placebo-controlled trial.
A n n a ls o f In te rn a l M ed icin e
130, 54 (1999).
J. H. Stein and R. S. Rosenson: Lipoprotein Lp(a) excess and coronary heart
disease.
A rch ives o f In te rn a l M ed icin e
1 5 7 , 1170 (1997).
N. G. Stephens, A. Parsons, P. M. Schofield, et al.: Randomised controlled
trial of vitamin E in patients with coronary disease: Cambridge Heart
Antioxidant Study (CHAOS).
L a n c e t
3 4 7 , 781 (1996).
T. Syrovets, J. Thellet, M. J. Chapman, and T. Simmet: Lipoprotein(a) is a
potent chemoattractant for human peripheral monocytes.
B lo o d
9 0 , 2027
(1997) .
A. Tybjaerg-Hansen, R. Steffensen, H. Meinertz, et al.: Association of muta-
tions in the apolipoprotein B gene with hypercholesterolemia and the risk
of ischemic heart disease.
N ew E n g la n d J o u rn a l o f M ed icin e
338,1577
(1998) .
J. L. Witztum: The oxidation hypothesis of atherosclerosis.
L a n c e t
3 4 4 ,793
(1994).
